In addition to breast cancer, higher levels of SLC31A1 were found in tumor samples of bladder, cervical, esophageal, uterine, stomach, head and neck cancers, as well as pheochromocytoma and paraganglioma, compared with normal samples. Here, SLC31A1 is linked to head and neck cancer.